Chamorro C, Aparicio M, Marmisa G, Martinez-Urrialde J L
Regional Transplant Coordination Office, Madrid, Spain.
Transplant Proc. 2009 Jul-Aug;41(6):2302-3. doi: 10.1016/j.transproceed.2009.06.102.
The Madrid Autonomous Region, a Spanish area with 6,200,000 inhabitants, has 7 hospitals authorized for organ transplantation, with 25 active programs for carrying out various transplantations: 18 for adults and 7 for children. Most of these hospitals are reference transplant centers for other Spanish regions. Between 715 and 760 transplantations are performed annually, which represents between 19% and 22% of Spanish activity. During 2007, 395 kidney, 220 liver, 55 heart, and 35 lung transplantations were performed, as well as 23 isolated or combination transplantations of other abdominal organs (pancreatic, intestinal, or multivisceral). Kidney, liver, heart, and children's intestinal transplant activity in 2007 represented 37%, 63%, 80%, and 100%, respectively, of all pediatric national activity. The Madrid Autonomous Region has a donation rate of 34.2 donors per million inhabitants. Of these, 30% are from non-heart-beating donors (NHBD), Maastrich criteria category 1 or 2. Various hospitals perform kidney, liver, and lung transplantations with these organs, representing 11% of the lung transplantations carried out in recent years, with this being a pioneer procedure worldwide. Despite the important transplant activity, we are working to increase donations, to improve organ donor detection and management protocols, as well as to reach a consensus on criteria to decrease the nonviability rates of potential transplant organs.
马德里自治区是西班牙的一个地区，有620万居民，有7家医院被授权进行器官移植，有25个开展各种移植手术的活跃项目：18个针对成人，7个针对儿童。这些医院中的大多数是西班牙其他地区的参考移植中心。每年进行715至760例移植手术，占西班牙移植活动的19%至22%。2007年，进行了395例肾脏移植、220例肝脏移植、55例心脏移植和35例肺移植，以及23例其他腹部器官（胰腺、肠道或多脏器）的单独或联合移植。2007年，肾脏、肝脏、心脏和儿童肠道移植活动分别占全国所有儿科移植活动的37%、63%、80%和100%。马德里自治区的捐赠率为每百万居民34.2名捐赠者。其中，30%来自非心脏跳动捐赠者（NHBD），马斯特里赫特标准1或2级。多家医院用这些器官进行肾脏、肝脏和肺移植，占近年来肺移植手术的11%，这在全球范围内是一项开创性的手术。尽管移植活动很重要，但我们仍在努力增加捐赠，改进器官捐赠者检测和管理方案，并就降低潜在移植器官不可用率的标准达成共识。
